EA200601816A1 - КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 5,11-ДИГИДРО-11-ЭТИЛ-5-МЕТИЛ-8-{2-{(1-ОКСИДО-4-ХИНОЛИНИЛ)ОКСИ}ЭТИЛ}-6Н-ДИПИРИДО[3,2-b:2',3'-e][1,4]ДИАЗЕПИН-6-ОНА - Google Patents

КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 5,11-ДИГИДРО-11-ЭТИЛ-5-МЕТИЛ-8-{2-{(1-ОКСИДО-4-ХИНОЛИНИЛ)ОКСИ}ЭТИЛ}-6Н-ДИПИРИДО[3,2-b:2',3'-e][1,4]ДИАЗЕПИН-6-ОНА

Info

Publication number
EA200601816A1
EA200601816A1 EA200601816A EA200601816A EA200601816A1 EA 200601816 A1 EA200601816 A1 EA 200601816A1 EA 200601816 A EA200601816 A EA 200601816A EA 200601816 A EA200601816 A EA 200601816A EA 200601816 A1 EA200601816 A1 EA 200601816A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ethyl
dipyrido
diazepin
dihydro
oxy
Prior art date
Application number
EA200601816A
Other languages
English (en)
Inventor
Карл А. Бусакка
Майкл Черетта
Ричард Варсолона
Джон Смолига
Джон Лоренц
Яна Витоус
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601816(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA200601816A1 publication Critical patent/EA200601816A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

В заявке описаны дигидратная и безводная кристаллические формы 5,11-дигидро-11-этил-5-метил-8-{2-{(1-оксидо-4-хинолинил)окси}этил}-6Н-дипиридо[3,2-b:2',3'-е][1,4]диазепин-6-она.
EA200601816A 2004-04-02 2005-03-23 КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 5,11-ДИГИДРО-11-ЭТИЛ-5-МЕТИЛ-8-{2-{(1-ОКСИДО-4-ХИНОЛИНИЛ)ОКСИ}ЭТИЛ}-6Н-ДИПИРИДО[3,2-b:2',3'-e][1,4]ДИАЗЕПИН-6-ОНА EA200601816A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55935404P 2004-04-02 2004-04-02
PCT/US2005/009655 WO2005097796A2 (en) 2004-04-02 2005-03-23 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

Publications (1)

Publication Number Publication Date
EA200601816A1 true EA200601816A1 (ru) 2007-04-27

Family

ID=34963561

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601816A EA200601816A1 (ru) 2004-04-02 2005-03-23 КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 5,11-ДИГИДРО-11-ЭТИЛ-5-МЕТИЛ-8-{2-{(1-ОКСИДО-4-ХИНОЛИНИЛ)ОКСИ}ЭТИЛ}-6Н-ДИПИРИДО[3,2-b:2',3'-e][1,4]ДИАЗЕПИН-6-ОНА

Country Status (19)

Country Link
US (1) US7309700B2 (ru)
EP (1) EP1740586A2 (ru)
JP (1) JP2007530681A (ru)
KR (1) KR20070014164A (ru)
CN (1) CN1938306A (ru)
AR (1) AR048360A1 (ru)
AU (1) AU2005230922A1 (ru)
BR (1) BRPI0509586A (ru)
CA (1) CA2558817A1 (ru)
EA (1) EA200601816A1 (ru)
EC (1) ECSP066904A (ru)
IL (1) IL178352A0 (ru)
MX (1) MXPA06011324A (ru)
NO (1) NO20064422L (ru)
PE (1) PE20060164A1 (ru)
TW (1) TW200602340A (ru)
UY (1) UY28827A1 (ru)
WO (1) WO2005097796A2 (ru)
ZA (1) ZA200605930B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009527466A (ja) * 2006-01-31 2009-07-30 タリオン ファーマシューティカルズ インク． ファルネシルジベンゾジアゼピノンの結晶形
EP2900240B1 (en) 2012-09-26 2020-01-08 Merck Sharp & Dohme Corp. Crystalline form of a reverse transcriptase inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI270547B (en) * 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) 2002-06-28 2004-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors

Also Published As

Publication number Publication date
JP2007530681A (ja) 2007-11-01
US20050222134A1 (en) 2005-10-06
WO2005097796A3 (en) 2006-01-05
US7309700B2 (en) 2007-12-18
WO2005097796A2 (en) 2005-10-20
PE20060164A1 (es) 2006-04-03
IL178352A0 (en) 2007-02-11
ZA200605930B (en) 2007-12-27
CN1938306A (zh) 2007-03-28
MXPA06011324A (es) 2007-03-21
EP1740586A2 (en) 2007-01-10
ECSP066904A (es) 2006-12-20
NO20064422L (no) 2006-09-29
TW200602340A (en) 2006-01-16
KR20070014164A (ko) 2007-01-31
AR048360A1 (es) 2006-04-19
UY28827A1 (es) 2005-10-31
AU2005230922A1 (en) 2005-10-20
BRPI0509586A (pt) 2007-10-09
CA2558817A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
EA200801663A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1'-(1-МЕТИЛЭТИЛ)-4'-[(2-ФТОР-4-МЕТОКСИФЕНИЛ)МЕТИЛ]-5'-МЕТИЛ-1H-ПИРАЗОЛ-3'-O-β-D-ГЛЮКОПИРАНОЗИДА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
EA200802213A1 (ru) Способы лечения заболеваний крови
NO20070782L (no) Tetrapeptidanaloger.
IS7215A (is) Aðferðir til að meðhöndla nýæðarsjúkdóma í augum
WO2007061737A3 (en) FUSED BICYCLIC mTOR INHIBITORS
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
ATE516291T1 (de) Thenopyrimidin-verbindungen mit fungizider aktivität
DK1781296T3 (da) Quinazolinderivater og deres anvendelse ved behandlingen af thrombocytæmi
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
NO20045554L (no) Fremgangsmate for behandling av diabetes
AT500499A3 (de) Mittelpunktbestimmung von justiermarken
DK1482936T3 (da) Öjenpræparat omfattende ascomycin
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
WO2004019879A3 (en) Motilide compounds
GB0526486D0 (en) Stockings of no wearing mark
CY2011018I1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
MY140538A (en) Substituted n-acyl-2-aminothiazoles
ZA200900165B (en) 4-amino-3-arylamino-6-arylpyrazolo[3,4-D]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
EA200601816A1 (ru) КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 5,11-ДИГИДРО-11-ЭТИЛ-5-МЕТИЛ-8-{2-{(1-ОКСИДО-4-ХИНОЛИНИЛ)ОКСИ}ЭТИЛ}-6Н-ДИПИРИДО[3,2-b:2',3'-e][1,4]ДИАЗЕПИН-6-ОНА
EA200601366A1 (ru) Кристаллическая форма мононатрия ризедроната
DK1188815T3 (da) Transparent, elastisk og fritstående forbindelse til fremstillingen af lys og fritstående lys opnået med denne forbindelse
DE60200268D1 (de) Einkristallzüchtungsverfahren
DE60121542D1 (de) Zweiachsiger Kreisel mit offener Regelschleife
DE602004020337D1 (de) Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege